Jongkyu Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jongkyu Choi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
David M. Shavelle
Division of Cardiovascular Medicine, Long Beach Medical Center, Long Beach, CA, USA
2 shared publications- Jorge Caro
Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
2 shared publications - Leonardo C. Clavijo
Adventist Heart & Vascular Institute, Saint Helena Hospital, St. Helena, CA, USA
2 shared publications - Ray V. Matthews
Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America
2 shared publications - Vincent Lopez Rowe
Division of Vascular Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
2 shared publications - Ashwat S. Dhillon
Division of Cardiovascular Medicine, Samaritan Health Services, Corvallis, OR, USA
1 shared publication
Latest Publications
- 28 November 2024
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 76, 91-97
Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study)
- 28 November 2024
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 76, 91-97
Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study)
- Open Access
- 16 October 2013
- Published by Springer Nature in Epigenetics & Chromatin
- Vol. 6 (1) , 34
Gene dysregulation by histone variant H2A.Z in bladder cancer
Background: The incorporation of histone variants into nucleosomes is one of the main strategies that the cell uses to regulate the structure and function of chromatin. Histone H2A.Z is an evolutionarily conserved histone H2A variant that is preferentially localized within nucleosomes at the transcriptional start site (TSS). H2A.Z reorganizes the local chromatin structure and recruits the transcriptional machinery for gene activation. High expression of H2A.Z has been reported in several types of cancers and is causally linked to genomic instability and tumorigenesis. However, it is not entirely clear how H2A.Z overexpression in cancer cells establishes aberrant chromatin states and promotes gene expression. Results: Through integration of genome-wide H2A.Z ChIP-seq data with microarray data, we demonstrate that H2A.Z is enriched around the TSS of cell cycle regulatory genes in bladder cancer cells, and this enrichment is correlated with the elevated expression of cancer-promoting genes. RNAi-mediated knockdown of H2A.Z in the cancer cells causes transcriptional suppression of multiple cell cycle regulatory genes with a distinct decrease in cell proliferation. H2A.Z nucleosomes around the TSS have higher levels of H3K4me2/me3, which coincides with the recruitment of two chromatin factors, WDR5 and BPTF. The observed recruitment is functional, as the active states of H2A.Z target genes are largely erased by suppressing the expression of WDR5 or BPTF, effects resembling H2A.Z knockdown. Conclusions: We conclude that H2A.Z is overexpressed in bladder cancer cells and contributes to cancer-related transcription pathways. We also provide evidence in support of the engagement of H3K4me2/me3 and WDR5/BPTF in H2A.Z-induced cancer pathogenesis. Further studies are warranted to understand how H2A.Z overexpression contributes to the recruitment of the full repertoire of transcription machinery to target genes in bladder cancer cells.
- 16 October 2013
- Published by Springer Nature in Epigenetics & Chromatin
- Vol. 6 (1) , 34
Open AccessGene dysregulation by histone variant H2A.Z in bladder cancer
Background: The incorporation of histone variants into nucleosomes is one of the main strategies that the cell uses to regulate the structure and function of chromatin. Histone H2A.Z is an evolutionarily conserved histone H2A variant that is preferentially localized within nucleosomes at the transcriptional start site (TSS). H2A.Z reorganizes the local chromatin structure and recruits the transcriptional machinery for gene activation. High expression of H2A.Z has been reported in several types of cancers and is causally linked to genomic instability and tumorigenesis. However, it is not entirely clear how H2A.Z overexpression in cancer cells establishes aberrant chromatin states and promotes gene expression. Results: Through integration of genome-wide H2A.Z ChIP-seq data with microarray data, we demonstrate that H2A.Z is enriched around the TSS of cell cycle regulatory genes in bladder cancer cells, and this enrichment is correlated with the elevated expression of cancer-promoting genes. RNAi-mediated knockdown of H2A.Z in the cancer cells causes transcriptional suppression of multiple cell cycle regulatory genes with a distinct decrease in cell proliferation. H2A.Z nucleosomes around the TSS have higher levels of H3K4me2/me3, which coincides with the recruitment of two chromatin factors, WDR5 and BPTF. The observed recruitment is functional, as the active states of H2A.Z target genes are largely erased by suppressing the expression of WDR5 or BPTF, effects resembling H2A.Z knockdown. Conclusions: We conclude that H2A.Z is overexpressed in bladder cancer cells and contributes to cancer-related transcription pathways. We also provide evidence in support of the engagement of H3K4me2/me3 and WDR5/BPTF in H2A.Z-induced cancer pathogenesis. Further studies are warranted to understand how H2A.Z overexpression contributes to the recruitment of the full repertoire of transcription machinery to target genes in bladder cancer cells.